Verified peer comparison
China SXT Pharmaceuticals vs UY Scuti Acquisition Financial Comparison
Direct answer
China SXT Pharmaceuticals and UY Scuti Acquisition are compared on the same basis.
The comparison uses 2026 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free China SXT Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- China SXT Pharmaceuticals Revenue
- 1,072,632 USD
- UY Scuti Acquisition Revenue
- 0 USD
- China SXT Pharmaceuticals Operating income
- -7,122,933 USD
- UY Scuti Acquisition Operating income
- -1,414,260 USD